Blonder Tongue Laboratories, Inc.
BDRL
$0.062
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 32.18% | 26.13% | -2.40% | 2.77% | -7.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.18% | 26.13% | -2.40% | 2.77% | -7.72% |
| Cost of Revenue | 22.79% | 44.18% | 16.14% | 28.72% | -31.52% |
| Gross Profit | 50.18% | -6.07% | -33.96% | -32.20% | 176.57% |
| SG&A Expenses | -6.92% | -2.66% | -4.69% | -11.86% | -31.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -24.67% | 34.80% | 4.86% | 6.03% | -0.87% |
| Operating Income | 112.63% | -465.48% | -55.92% | -18.31% | -11.97% |
| Income Before Tax | 109.87% | -249.75% | -170.97% | -178.74% | 61.97% |
| Income Tax Expenses | -- | -- | -- | -- | 0.00% |
| Earnings from Continuing Operations | 109.71% | -249.75% | -170.97% | -178.74% | 61.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 109.71% | -249.75% | -170.97% | -178.74% | 61.58% |
| EBIT | 112.63% | -465.48% | -55.92% | -18.31% | -11.97% |
| EBITDA | 113.91% | -22,550.00% | -76.27% | -25.29% | -11.85% |
| EPS Basic | 109.20% | -221.34% | -163.89% | -147.61% | 68.96% |
| Normalized Basic EPS | 103.15% | -220.39% | -622.67% | -147.30% | 8.45% |
| EPS Diluted | 107.49% | -163.50% | -182.34% | -147.61% | 62.32% |
| Normalized Diluted EPS | 103.15% | -220.39% | -818.64% | -147.30% | 8.45% |
| Average Basic Shares Outstanding | 4.80% | 9.05% | 11.12% | 12.67% | 23.76% |
| Average Diluted Shares Outstanding | 4.80% | 9.05% | -12.70% | 12.67% | 23.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
